FR05C0045I1 - - Google Patents

Info

Publication number
FR05C0045I1
FR05C0045I1 FR05C0045C FR05C0045I1 FR 05C0045 I1 FR05C0045 I1 FR 05C0045I1 FR 05C0045 C FR05C0045 C FR 05C0045C FR 05C0045 I1 FR05C0045 I1 FR 05C0045I1
Authority
FR
France
Prior art keywords
pct
date sep
sec
pub
antiobiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR05C0045I1 publication Critical patent/FR05C0045I1/fr
Application granted granted Critical
Publication of FR05C0045I2 publication Critical patent/FR05C0045I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR05C0045C 1993-03-12 2005-11-17 Active FR05C0045I2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3329193A 1993-03-12 1993-03-12
PCT/US1994/001862 WO1994020505A1 (en) 1993-03-12 1994-03-07 Crystalline ceftiofur free acid

Publications (2)

Publication Number Publication Date
FR05C0045I1 true FR05C0045I1 (pt) 2006-01-06
FR05C0045I2 FR05C0045I2 (pt) 2007-08-03

Family

ID=21869579

Family Applications (1)

Application Number Title Priority Date Filing Date
FR05C0045C Active FR05C0045I2 (pt) 1993-03-12 2005-11-17

Country Status (31)

Country Link
US (1) US5721359A (pt)
EP (1) EP0690864B1 (pt)
JP (1) JP3852946B2 (pt)
KR (1) KR100296810B1 (pt)
CN (1) CN1055090C (pt)
AT (1) ATE202109T1 (pt)
AU (1) AU694419B2 (pt)
BR (1) BR1101034A (pt)
CA (1) CA2155322C (pt)
CZ (1) CZ289332B6 (pt)
DE (2) DE122005000055I2 (pt)
DK (1) DK0690864T3 (pt)
ES (1) ES2157254T3 (pt)
FI (1) FI120307B (pt)
FR (1) FR05C0045I2 (pt)
GR (1) GR3036514T3 (pt)
HU (1) HU222244B1 (pt)
IL (1) IL108910A (pt)
LU (1) LU91206I2 (pt)
LV (1) LV12889B (pt)
NL (1) NL300208I2 (pt)
NO (2) NO313199B1 (pt)
NZ (1) NZ263002A (pt)
PL (1) PL184611B1 (pt)
PT (1) PT690864E (pt)
RU (1) RU2136685C1 (pt)
SI (1) SI0690864T1 (pt)
SK (1) SK283674B6 (pt)
TW (1) TW267170B (pt)
WO (1) WO1994020505A1 (pt)
ZA (1) ZA941586B (pt)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
DK1317256T3 (da) * 2000-09-12 2009-01-26 Pharmacia & Upjohn Co Llc Farmaceutisk sammensætning havende en modificeret bærer
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
WO2003006441A1 (en) * 2001-07-10 2003-01-23 Pharmacia & Upjohn Company Crystalline thiazine oxazolidinones
ES2705063T3 (es) * 2001-08-15 2019-03-21 Pharmacia & Upjohn Co Llc Un cristal que comprende una sal de ácido L-málico de N-[2-(dietilamino)etil]-5-[(5-fluoro-1,2-dihidro-2-oxo-3H-indol-3-iliden)metil]-2,4-dimetil-1H-pirrol-3-carboxamida para su uso como un medicamento
AU2003230697B2 (en) 2002-03-21 2008-07-17 Zoetis Services Llc Method of administering an injectable antibiotic to the ear of an animal
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US20040115822A1 (en) * 2002-09-12 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US20040115837A1 (en) * 2002-11-27 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
AU2004224181B2 (en) * 2003-03-27 2011-06-02 Basilea Pharmaceutica Ag Cephalosporin in crystalline form
PT2156824E (pt) 2004-03-25 2013-01-04 Astellas Pharma Inc Uma composição de solifenacina, ou um seu sal, utilizada sob a forma de formulações sólidas
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
US8212024B2 (en) * 2005-10-12 2012-07-03 Orchid Chemicals & Pharmaceuticals Ltd. Crystalline sodium salt of cephalosporin antibiotic
US8470809B2 (en) * 2005-10-12 2013-06-25 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
EA016687B8 (ru) 2007-08-22 2012-07-30 Астразенека Аб Производные циклопропиламида
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8431562B2 (en) * 2008-08-22 2013-04-30 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
JP5685193B2 (ja) * 2008-11-19 2015-03-18 メリアル リミテッド セフチオフルおよびケトプロフェンとまたはセフチオフルとベンジルアルコールとを含む製剤
AR075153A1 (es) * 2009-01-30 2011-03-16 Glaxosmithkline Llc Compuesto hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil]etil)-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2- tiofenocarboxamida en forma cristalina, composicion farmaceitica que lo comprende, procedimiento para prepararla, su uso para preparar un medicamento util para tratar o disminuir la
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
KR20130034009A (ko) * 2010-02-18 2013-04-04 아스트라제네카 아베 시클로프로필 아미드 유도체를 포함하는 고체 형태
RU2012139082A (ru) * 2010-02-18 2014-03-27 Астразенека Аб Способы получения производных циклопропиламида и связанных с ними промежуточных соединений
AU2012251438A1 (en) 2011-05-02 2013-11-14 Pfizer Inc. Novel cephalosporins useful as antibacterial agents
CA2842462C (en) 2011-07-20 2020-01-28 Brigham Young University Hydrogel materials incorporating eluting ceragenin compound
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
BR112014005914B1 (pt) 2011-09-13 2021-11-09 Brigham Young University Produtos para cicatrização de feridas tecidulares
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
EP2755661A1 (en) 2011-09-13 2014-07-23 Brigham Young University Compositions for treating bone diseases and broken bones
WO2013109236A2 (en) 2011-12-21 2013-07-25 Colgate-Palmolive Company Oral care compositions
CN102584855B (zh) * 2012-02-16 2014-06-25 青岛科技大学 一种改进的头孢噻呋的制备方法
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
WO2013165574A2 (en) 2012-05-02 2013-11-07 Brigham Young University Ceragenin particulate materials and methods for making same
NZ707003A (en) 2012-10-17 2016-04-29 Univ Brigham Young Treatment and prevention of mastitis
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
EP2941253B1 (en) 2013-01-07 2021-08-11 Brigham Young University Cationic steroid antimicrobial agents for use in treating cancer
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
KR102282183B1 (ko) 2013-03-15 2021-07-26 브라이엄 영 유니버시티 염증, 자가면역 장애 및 통증의 치료 방법
RU2546675C2 (ru) * 2013-04-11 2015-04-10 Федеральное казённое предприятие "Государственный научно-исследовательский институт химических продуктов" (ФКП "ГосНИИХП") Способ определения степени кристалличности составов на основе дифениламина
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
CN105517992B (zh) * 2013-09-05 2018-06-22 田边三菱制药株式会社 新型结晶性芳烷基胺化合物及其制造方法
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
ES2813726T3 (es) * 2014-10-21 2021-03-24 Ariad Pharma Inc Formas cristalinas de 5-cloro-N4-[-2-(dimetilfosforilo)fenilo]-N2-{2-metoxi-4-[4-(4-metilpiperazina-1-ilo)piperidina-1- ilo]pirimidina-2,4-diamina
WO2016172543A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
KR101753842B1 (ko) * 2015-05-12 2017-07-04 한국화학연구원 불화퀴놀론계 항생제를 담지한 서방형 제제 및 이의 제조방법
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
CN106543203B (zh) * 2015-09-18 2019-07-02 瑞普（天津）生物药业有限公司 一种长效头孢噻呋自由酸晶体的制备方法
EP3778567A1 (en) * 2016-01-22 2021-02-17 Sandoz Ag Crystalline eravacycline bis-hydrochloride
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
KR101898282B1 (ko) * 2016-05-24 2018-09-13 주식회사 고려비엔피 항생제의 서방형 수의학적 조성물 및 이의 제조방법
EA039753B1 (ru) * 2016-07-07 2022-03-10 Сайклерион Терапьютикс, Инк. ТВЕРДЫЕ ФОРМЫ СТИМУЛЯТОРА sGC
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
TW202233625A (zh) * 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1207933B (de) * 1962-12-26 1965-12-30 American Home Prod Verfahren zur Herstellung von kristallwasser-freiem D-alpha-Aminobenzylpenicillin
CY773A (en) * 1967-09-05 1975-03-01 Bristol Myers Co Antibacterial agents and a process for the preparation thereof
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
IT1181672B (it) * 1984-10-25 1987-09-30 Upjohn Co Cefalosporina alogenidrato cristallino
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
DE3650526T2 (de) * 1985-08-12 1996-10-31 Upjohn Co Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
GB8608962D0 (en) * 1986-04-12 1986-05-14 Beecham Group Plc Beta-lactam antibiotics
IT1214587B (it) * 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.
EP0278656B1 (en) * 1987-02-02 1992-06-03 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
WO1989000852A1 (en) * 1987-07-29 1989-02-09 The Upjohn Company Controlled release of antibiotic salts from an implant
US5134137A (en) * 1987-11-10 1992-07-28 The Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes

Also Published As

Publication number Publication date
HUT73781A (en) 1996-09-30
WO1994020505A1 (en) 1994-09-15
PL310556A1 (en) 1995-12-27
FR05C0045I2 (pt) 2007-08-03
SK283674B6 (sk) 2003-11-04
DE69427469D1 (en) 2001-07-19
DE122005000055I2 (de) 2008-06-05
DE69427469T2 (de) 2001-10-31
AU694419B2 (en) 1998-07-23
GR3036514T3 (en) 2001-12-31
NO2005025I2 (no) 2010-11-22
CA2155322C (en) 2000-02-29
AU6351094A (en) 1994-09-26
SI0690864T1 (en) 2001-10-31
CN1119016A (zh) 1996-03-20
ZA941586B (en) 1995-09-07
KR100296810B1 (ko) 2001-10-24
RU2136685C1 (ru) 1999-09-10
BR1101034A (pt) 2002-04-30
PT690864E (pt) 2001-11-30
NL300208I1 (nl) 2006-02-01
NO953564D0 (no) 1995-09-11
IL108910A0 (en) 1994-06-24
CZ9502290A3 (cs) 2001-08-15
ES2157254T3 (es) 2001-08-16
FI954250A (fi) 1995-09-11
CZ289332B6 (cs) 2002-01-16
EP0690864B1 (en) 2001-06-13
NO313199B1 (no) 2002-08-26
NZ263002A (en) 1996-12-20
DK0690864T3 (da) 2001-09-17
FI120307B (fi) 2009-09-15
US5721359A (en) 1998-02-24
CN1055090C (zh) 2000-08-02
HU9501960D0 (en) 1995-09-28
DE122005000055I1 (de) 2006-02-23
PL184611B1 (pl) 2002-11-29
JP3852946B2 (ja) 2006-12-06
ATE202109T1 (de) 2001-06-15
LV12889B (lv) 2002-12-20
NO2005025I1 (no) 2005-12-05
JPH08507519A (ja) 1996-08-13
NO953564L (no) 1995-11-07
EP0690864A1 (en) 1996-01-10
SK111495A3 (en) 1995-12-06
CA2155322A1 (en) 1994-09-15
IL108910A (en) 1999-10-28
TW267170B (pt) 1996-01-01
HU222244B1 (hu) 2003-05-28
FI954250A0 (fi) 1995-09-11
LU91206I2 (fr) 2006-05-30
NL300208I2 (nl) 2006-05-01

Similar Documents

Publication Publication Date Title
FR05C0045I2 (pt)
HUT72970A (en) Risperidone pamoate, pharmaceutical composition containing it and process for their production
PL312739A1 (en) New derivatives of perhydro isoindole, their production and pharmaceutical compounds containing them
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
PL310171A1 (en) Novel imidazopyridines
HUT71584A (en) Lipopeptide derivatives and pharmaceutical compositions containing them
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
GB9126725D0 (en) Process
AU1067295A (en) Substituted aminoalkylaminopyridines
ES8606272A1 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
AU681373B2 (en) Process for preparing C-substituted diethylene triamines